Nonin Medical Marking Milestone Anniversary Year

This is a ruby red year for Nonin Medical.

The global manufacturer of wearable and noninvasive patient monitoring solutions is celebrating its 40th anniversary in 2026, marking four decades of innovation in patient monitoring and solidifying its role as a partner to clinicians, sleep specialists, home care providers, respiratory therapists, and OEM customers worldwide. This milestone marks the company’s role in helping shape modern noninvasive patient monitoring while reinforcing its long-term commitment to accuracy, quality, and customer partnership. As part of this milestone year, the appointment of Todd Austin as CEO positions a seasoned clinician-executive to guide the next chapter of growth.

Founded in 1986 by engineer and entrepreneur Phil Isaacson, Nonin was built on the principle that accurate measurements matter. When clinicians can trust the data in front of them, they make better decisions, and better decisions lead to better patient outcomes. That philosophy—earning trust through consistency, evidence, and engineering discipline—became the foundation of Nonin’s culture and remains embedded in every solution the company develops.

“From the very beginning, our goal was to give clinicians data they could depend on without question. Trust is earned through consistency, evidence, and performance. For four decades, every product we have ever built starts and ends with those standards,” Nonin Medical Founder/Executive Board Chairman/Chief Technology Officer Phil Isaacson said.

In 1995, the company introduced the world’s first fingertip pulse oximeter. At the time, pulse oximetry was largely confined to larger hospital-based systems. Nonin’s innovation miniaturized the technology without compromising accuracy or durability, fundamentally redefining accessibility in patient monitoring. The fingertip oximeter established new benchmarks for reliability and clinical trust, benchmarks that continue to guide the company’s product development today, according to executives. After 40 years, Nonin’s technology is embedded in hospitals, home health settings, sleep laboratories, research institutions, and OEM platforms in more than 125 countries.

For four decades, Nonin has been a partner in the full spectrum of noninvasive monitoring—from critical respiratory care to sleep medicine. In respiratory care, accurate measurements are essential for assessing and managing rapidly growing chronic conditions such as COPD and asthma. In sleep medicine, Nonin’s technology provides the data clinicians use to diagnose and manage obstructive sleep apnea, one of the most prevalent and underdiagnosed conditions globally. Across both disciplines—and in home-based and connected care settings—Nonin’s solutions have served as a consistent, clinically trusted partner for patients and providers alike.

As healthcare delivery increasingly extends beyond traditional hospital walls into homes, decentralized research models, and digitally connected ecosystems, the need for accurate, reliable noninvasive data has only intensified. To guide the company into this next chapter of more connected care provision, Nonin will be guided by Austin, who has spent more than four decades understanding respiratory care from both the bedside and the boardroom.

A registered respiratory therapist, registered pulmonary function technologist, and neonatal-pediatric specialist, Austin began his career at the bedside in the early 1980s, caring for critically ill patients in neonatal and pediatric intensive care. Austin witnessed the emergence of pulse oximetry as the “fifth vital sign,” a transformation that fundamentally changed the way clinicians assess and manage respiratory conditions. Over a career spanning SensorMedics, VIASYS Healthcare, CareFusion, and, most recently, as president and CEO of MGC Diagnostics, Austin has translated clinical insight into commercial leadership across pulmonary diagnostics, sleep medicine, and global medical technology.

“Nonin was a familiar part of my clinical work long before I ever imagined leading the company. As a clinician, you learn very quickly that accuracy is not a feature; it’s a responsibility. Forty years of trust is something you protect fiercely, even as you push forward with the next wave of innovation,” Austin commented.

“Todd brings a rare combination of clinical credibility, operational leadership, and deep respect for the culture that has sustained Nonin for 40 years. This is not a moment of reinvention; it’s a moment of sustained evolution and continued innovation. Todd understands what must remain unchanged, and where we have an opportunity to lead for decades to come,” Isaacson explained.

Austin’s vision for Nonin’s next chapter centers on expanding the company’s legacy of accuracy and the capabilities it can deliver as healthcare evolves rapidly toward connected, home-based, and personalized care models. That means building on the company’s hardware foundation with integrated software solutions, including Nonin Health, the company’s cloud-based data platform, designed to transform accurate, dependable SpO₂ data into actionable clinical and physiological insights accessible across care settings. It also means ensuring accuracy and equity reach patients wherever care takes place, including in remote and underserved communities.

“Our legacy of accuracy is strong. Our future of innovation is even stronger. What excites me most is the shift toward proactive, connected care that can reach patients wherever they are, and the recognition that its success depends on one fundamental principle: the data must be accurate, reliable, and accessible. For 40 years, that has been Nonin’s standard. As care becomes more connected and more personal, that foundation becomes even more critical,” Austin continued.

Nonin will celebrate its 40th anniversary throughout 2026 with initiatives honoring its history, its customers and partners, and the future of noninvasive monitoring. Advances in miniaturization, connectivity, and analytics are enabling more personalized monitoring strategies, moving beyond comparisons to population norms toward a clearer understanding of individual patient baselines. In respiratory and sleep care alike, ensuring that these emerging models are built on dependable data and insights remains central to Nonin’s direction.

Since 1986, Nonin Medical has developed technologies and manufactured durable noninvasive patient monitoring devices for healthcare professionals and consumers.